SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001694665-20-000033
Filing Date
2020-04-27
Accepted
2020-04-27 16:10:53
Documents
5
Effectiveness Date
2020-04-27

Document Format Files

Seq Description Document Type Size
1 DEFA14A eveloproxy2019defa14a.htm DEFA14A 31708
2 noticeandaccesscard-defa11.jpg GRAPHIC 167521
3 noticeandaccesscard-defa21.jpg GRAPHIC 231254
4 noticeandaccesscard-defa31.jpg GRAPHIC 79569
5 noticeandaccesscard-defa41.jpg GRAPHIC 52116
  Complete submission text file 0001694665-20-000033.txt   763861
Mailing Address 620 MEMORIAL DRIVE SUITE 200 WEST CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 200 WEST CAMBRIDGE MA 02139 617 870 8281
Evelo Biosciences, Inc. (Filer) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38473 | Film No.: 20820061
SIC: 2834 Pharmaceutical Preparations